GOP Congressman Who Used Psychedelics For Mental Health Slams FDA Panel’s MDMA Rejection (Op-Ed)

Thu, Jun 13

An FDA committee's rejection of MDMA "highlights the persistent barriers and misconceptions that continue to hinder progress with emerging therapies," @RepLuttrell, who personally benefitted from psychedelics therapy, says in an op-ed for MM. https://t.co/FGxwSp2X8n

9661

“These therapies, as a multitude of trials have shown, provide a lifeline for countless individuals for whom conventional therapies have proven insufficient.” By Rep. Morgan Luttrell (R-TX) In recent...

Discover